Skip to content
Home
About Us
Personnel
PIR Multichannel
Argyll Metals
Anglesey Mining (AYM)
Blencowe Resources (BRES)
Cadence Minerals (KDNC)
ECR Minerals (ECR)
First Class Metals (FCM)
First Development Resources (FDR)
GreenX Metals (GRX)
Mendell Helium (MDH)
Penina Investments Plc
Quantum Helium (QHE)
Seed Capital Solutions Plc (SCSP)
Sovereign Metals (SVML)
URU Metals (URU)
Research
News and Views
Track Record
Contact
Disclosure
Home
About Us
Personnel
PIR Multichannel
Argyll Metals
Anglesey Mining (AYM)
Blencowe Resources (BRES)
Cadence Minerals (KDNC)
ECR Minerals (ECR)
First Class Metals (FCM)
First Development Resources (FDR)
GreenX Metals (GRX)
Mendell Helium (MDH)
Penina Investments Plc
Quantum Helium (QHE)
Seed Capital Solutions Plc (SCSP)
Sovereign Metals (SVML)
URU Metals (URU)
Research
News and Views
Track Record
Contact
Disclosure
Two exciting late stage clinical assets – XF-73 and NTCD-M3
China Medical Systems – new XF-73 programme in China
NTCD-M3 Phase 3 studies
Spore COV – JV progress and Innovate funding
Cash runway and upcoming value inflection points
Tagged
brand communications ceo alan green
,
China Medical Systems
,
dest
,
destiny pharma
,
Neil Clark
,
NOVUS COMMUNICATIONS CEO ALAN GREEN
,
NTCD-M3
,
Spore COV
,
XF-73